mRNA-0523-L001

· Shanghai Jiao Tong University School of Medicine

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for mRNA-0523-L001, covering 2026-04-09 to 2026-04-09. Get the full timeline:

Most recent: Clinical Trial Update: Treatment of Advanced Endocrine Tumor With Iindividualized mRNA Neoantigen Vaccine (mRNA-0523-L001) [NA]